Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)
China flag China · Delayed Price · Currency is CNY
22.93
-0.34 (-1.46%)
Mar 9, 2026, 3:00 PM CST

SHA:688298 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-529.02-397.582,0684,920
Depreciation & Amortization
204.24165.4986.5637.31
Other Amortization
24.12188.512.27
Loss (Gain) From Sale of Assets
-0.990.180.01-0.01
Asset Writedown & Restructuring Costs
81.7563.86366.580.05
Loss (Gain) From Sale of Investments
-24.6-48.85-7.66-11.22
Provision & Write-off of Bad Debts
30.130.17-6.4432.55
Other Operating Activities
-8.2496.57378.84109.18
Change in Accounts Receivable
-109.37210.28825.4-692.05
Change in Inventory
1.91-86.23-775.13-98.7
Change in Accounts Payable
-11.52-1,670172.34928.52
Change in Other Net Operating Assets
15.78---
Operating Cash Flow
-348.33-1,6462,9965,204
Operating Cash Flow Growth
---42.43%190.67%
Capital Expenditures
-924.09-996.05-1,052-507.87
Sale of Property, Plant & Equipment
7.510.812.581.79
Cash Acquisitions
-320.76-78.52-184.87-43.71
Investment in Securities
678.2681.54-1,076228.15
Other Investing Activities
-111.06-1,126-65.22-
Investing Cash Flow
-670.15-2,118-2,376-321.64
Long-Term Debt Issued
300.7577250-
Total Debt Issued
300.7577250-
Long-Term Debt Repaid
-459.27-331.82-6.21-6.97
Total Debt Repaid
-459.27-331.82-6.21-6.97
Net Debt Issued (Repaid)
-158.52440.1843.79-6.97
Repurchase of Common Stock
-276.95---
Common Dividends Paid
-16.63-351.14-742.04-504.67
Other Financing Activities
0.36-39.51-2.47
Financing Cash Flow
-451.7449.54-698.25-509.17
Foreign Exchange Rate Adjustments
51.8985.85536.65-75.44
Net Cash Flow
-1,418-3,628458.624,298
Free Cash Flow
-1,272-2,6421,9444,696
Free Cash Flow Growth
---58.60%182.32%
Free Cash Flow Margin
-153.69%-322.09%22.17%46.18%
Free Cash Flow Per Share
-6.47-13.099.6423.29
Cash Income Tax Paid
-13.59-24.311,112260.08
Levered Free Cash Flow
-1,255-2,3791,5133,361
Unlevered Free Cash Flow
-1,243-2,3681,5173,362
Change in Working Capital
-125.68-1,573101.82113.54
Source: S&P Global Market Intelligence. Standard template. Financial Sources.